Formatech, founded in 1993, is dedicated to accelerating drug development by providing innovative solutions to product development and manufacturing challenges. The company's core mission is to expedite the creation of new drugs at the speed of science. Formatech offers a range of services including preformulation and formulation development for various dosage forms, lyophilization development, cell culture and fermentation process development, purification and downstream process development, and aseptic fill and finish of both liquid and lyophilized products. Their market focus is on pharmaceutical companies seeking efficient and reliable drug development processes.
Notable figures affiliated with Formatech include industry experts in pharmaceutical sciences and bioprocessing. The company has garnered attention from key investors in the biotech sector, contributing to its growth and innovation. Formatech's key achievements include successful partnerships with leading pharmaceutical firms and the development of numerous drug formulations that have advanced to clinical trials. The overall impact of Formatech lies in its ability to streamline drug development, thereby accelerating the availability of new therapies to patients in need.
Quick Facts
When was Forma's last funding round?
Forma's most recent funding round was for $7M (USD) in January 2020.
How much disclosed funding has Forma raised?
As of Jan 31, 2020, Forma has disclosed funding of $7M (USD).
